Identification of biomarkers representing the evolution of the pathophysiology of Post Traumatic Stress Disorder (PTSD) is vitally important, not only for objective diagnosis but also for the evaluation of therapeutic efficacy and resilience to trauma. Ongoing research is directed at identifying molecular biomarkers for PTSD, including traumatic stress induced proteins, transcriptomes, genomic variances and genetic modulators, using biologic samples from subjects' blood, saliva, urine, and postmortem brain tissues. However, the correlation of these biomarker molecules in peripheral or postmortem samples to altered brain functions associated with psychiatric symptoms in PTSD remains unresolved. Here, we present an animal model of PTSD in which both peripheral blood and central brain biomarkers, as well as behavioral phenotype, can be collected and measured, thus providing the needed correlation of the central biomarkers of PTSD, which are mechanistic and pathognomonic but cannot be collected from people, with the peripheral biomarkers and behavioral phenotypes, which can.
The stress exposure protocol is a continuous 2-hr procedure, where each session consists of restraint ("inescapable") and tail-shocks, repeated once a day over 3 consecutive days. Stressing is done in the morning (within the window of 0800 and 1200). Animals are restrained by being immobilized in a ventilated plexiglass tube. Forty electric shocks (2 mA, 3 sec duration; Animal Test Cage Grid Floor Shocker, Coulbourn Instruments, USA) are delivered to their tails at semi-random intervals of 150 to 210 sec (Graphic State Notation software, Habitest Universal Link, Coulbourn Instruments, USA). Stimulation at 2 mA was chosen because it is aversive, but not painful, when the stimulating output is placed across the experimenter's finger. Electrode gel is applied using Q-tip to form a thin layer of conducting gel between electrode and the skin of the rat's tail. The electrode clips are adjusted and connected to the tail to ensure a good connection without affecting the blood circulation of the tail. 5. Acoustic Startle Response (ASR): Acoustic startle response measurement was conducted with a Startle Response Acoustic Test System (Coulbourn Instruments, Columbus, Ohio, USA) 3 . This system consists of weight-sensitive platforms in a sound-attenuated chamber. The transducer, which is a strain gauge, in each of the startle platforms requires calibration before use. First, the coupler must be in the DC coupled mode for calibration. In this mode, the coupler's output directly follows the input from the platform, the mode required for calibration with static weights. The transducer is switched to the AC coupled mode during experiments so that only rapid change in force, which indicates startle response, is output. The animals' movements in response to sound stimuli are thus measured as a voltage change by a strain gauge inside each platform and recorded as the maximum response occurring within 200 ms of the onset of the startle-eliciting stimulus. There are six types of stimulus trials: 100 dB alone, 100 dB with pre-pulse, 110 dB alone, 110 dB with pre-pulse, pre-pulse alone and no stimulus control. Each trial type was presented eight times. Trial types are presented in random order to avoid order effects and habituation. Inter-trial intervals range randomly from 15 to 25 sec. Among the eight trials only the maximum values are collected in the results and finally adjusted with the animal body weight of the same day. Animals are tested one day before stress or other treatment as a baseline reading and 1, 7, 14 and 21 days following the final day of the consecutive 3 days of the stress procedure or other treatment. 6. Data analysis:
1. ASR: The amplitude of acoustic startle response tested each time is represented as "% of baseline", which is calculated using the equation: % of baseline = (absolute amplitude /baseline absolute amplitude) ×100%. For each test day, ANOVAs for repeated measures are performed on startle amplitudes with factors of stress status and drug dosage using SPSS (Version 16) software. Tukey, Bonferroni, or Dunnett tests are used to assess significant post-hoc differences between individual groups. The data are represented as mean ± S.E.M. 2. Growth: Body weight and food and water consumption are measured on Day -1 preceding stress and on Days 14, 21 and 30 following completion of the stress protocol. Statistical analysis: Food and water intake data are subjected to one-way repeated-measures analysis of variance (ANOVA). To analyze the changes in food consumption rate over time, the amount of food intake is further divided by the body weight of the subject to minimize the variance in body weight induced by the stress protocol and initial difference in the body weight between the groups. All procedures are conducted under the approval in accordance with the Institutional Animal Care and Use Committee (IACUC). 0.5 X SSC/0.01 SDS 500 ml 12.5 ml 0.5 ml up to 500 ml 0.5 X SSC 500 ml 12.5 ml up to 500 ml 0.1 X SSC 500 ml 2.5 ml up to 500 ml 0.01 X SSC 500 ml 0.25 ml up to 500 ml
Brain Dissection
During the washing the slides should be protected from light. Do not let slides dry out at any stage. 5. Data analysis: The customized computational procedures for microarray data analysis include microarray image evaluation, data filtering, spot size correction, inclusion, normalization and comparison as described previously 18 . In addition, the methods for ontology, pathway and network analyses are the same as described previously in order to assure the generation of reproducible and verifiable microarray results Our application of the rMNChip and bioinformatic tools led to identification of a cluster and heatmap of 64 genes with differentially expressed RNA derived from 5 rat brain tissues including cerebellum (CL), cerebrum (CR), frontal cortex (FC), hypothalamus (HT), and hippocampus (HC) (Figure 4 ). These data demonstrate the clear differences in mitochondrial gene expression and therefore related functions. The results demonstrate that the different brain regions demand different amount of energy in order to carrying out corresponding brain functions.
Discussion
The diagnosis of PTSD is based on self reported psychiatric symptoms (DSM IV) by potential subjects. No well defined biomarker is currently available to access the pathophysiological status of potential PTSD patients. PTSD is a disorder provoked by life threatening traumatic events and the main psychiatric symptoms remain present in the survivor's life for months and even years after the initial events. The most prominent and persistent symptoms revealed in patients with PTSD are hypervigilance, delayed exaggerated startle response 14, 15, 16 and an apparent compromise of the HPA axis. In humans these symptoms remain, or appear with a delay of three months, after cessation of the traumatic stressor 24 . Our current model for biomarker studies of PTSD employs restraint and tail shocks repeated for three continuous days (2-hr sessions of 40, 2 mA tailshocks) -the inescapable tail-shock model (ITS) in rats weighing 150 gram. This ITS model has been shown to mimic to a substantial extent the pathophysiology of PTSD 17, 7, 4, 10 . Our lab and other labs have verified that the ITS model of stress in rats induces behavioral and neurobiological alterations that are similar to those found in PTSD subjects 17, 7, 10, 9 . Specifically, these stressed rats exhibit (1) a delayed and exaggerated startle response appearing several days after stressor cessation, which given the compressed time scale of the rat's life compared to a humans, corresponds to the one to three months delay of symptoms in PTSD patients(DSM-IV-TR PTSD Criterian D/E 13 ), (2) enhanced plasma corticosterone (CORT) for several (10) days, indicating compromise of the hypothalamopituitary axis (HPA), and (3) retarded body weight gain after stressor cessation, corresponding to the dysfunction of metabolic regulation of PTSD. There is no evidence in experiment compared the startle response of 3DS and 1DS rats 4, 7, and 10 days after stressor cessation. Consistent with previous work, stressed rats exhibited elevated basal plasma CORT levels the first day post stress 17 . These CORT levels were sensitive to the number of stressor exposures with higher CORT levels in 3DS rats than in 1DS rats. As for startle response, the 1DS rats exhibit an exaggerated startle response 7 days post stressor, whereas startle sensitization only becomes apparent 10 days post stressor in 3DS rats. Thus, the appearance of an exaggerated startle response after stressor cessation appears to be related to the number of stress session exposures. The 3DS stressed model appears to be useful to gain insight into the altered expression of biomarkers associated with the symptoms of PTSD and the key measurable behavioral phenotypes associated with the timing following the cessation of stress. Genomic results presented provide proof of principle for applying rMNChip and bioinformatics tools to identify differential pathways, and gene and protein biomarkers, which will greatly facilitate systems-biological study and understanding of molecular mechanisms underlying complex and multifactorial neurologic disorders, including PTSD.
While our paradigm does not delve into the cognitive and more complex behavioral aspects of PTSD, we note that altered sleep patterns in the ITS model 1 correspond to the difficulty falling and staying asleep and the nightmares of PTSD patients 11 (DSM-IV-TR PTSD Criteria D 13 ), and the deficiencies in escape/avoidance learning and learning of an appetitive task in the ITS model 12 corresponds to the poor concentrations and memory deficits of PTSD 5 (DSM-IV-TR PTSD Criteria C
13
). The current model correlates well with the key symptoms characteristic of PTSD and provides a good model for correlating peripheral biomarkers of PTSD, which can be collected from patients, with central, mechanistic biomarkers, which cannot 6 .
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